Clinical Trials Insight: 700033614

Trial Profile

Clinical Trials Insight: 700033614

Not stated
Phase of Trial: Phase III

Latest Information Update: 11 Mar 2013

At a glance

  • Drugs Atorvastatin/fenofibrate (Primary)
  • Indications Lipid metabolism disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Veloxis Pharmaceuticals
  • Most Recent Events

    • 11 Mar 2013 Status changed from planning to unconfirmed.
    • 17 May 2008 This program is expected to begin patient enrolment in the second half of 2008.
    • 15 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top